Advertisement
asthma
asthma
11/15/2017
The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.
11/15/2017
asthma
asthma
09/12/2017
Previous studies have suggested that benralizumab could help improve lung function and reduce asthma exacerbations among patients with severe, uncontrolled asthma. In a recent study, researchers...
09/12/2017
COPD
COPD
05/03/2017
Researchers investigated the correlation and predictive relationship between fractional exhaled nitric oxide levels and sputum eosinophils in patients with COPD.
05/03/2017
Asthma
Asthma
09/25/2016
Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, is safe and effective in treatment of severe uncontrolled, eosinophilic asthma, according to two new industry-funded studies.
09/25/2016